OUR STUDY

THE PROMISE study is the first study to test healthy people who may be at risk for early warning signs of a blood cancer called multiple myeloma.

We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer.

OUR GOALS

This study aims to make multiple myeloma a cancer that is preventable.

Who can join and get screened at no cost?

2 groups of U.S. adults, age 45-75, qualify for a free screening:

African Americans AND / OR
People of Any Race Who Have a parent, sibling, or child with multiple myeloma or one these related conditions:
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Smoldering Multiple Myeloma
- Waldenström Macroglobulinemia

SparkCures ID	979
Trial Phase	Observational Trial
Enrollment	50000 Patients
Tags	Participate From Home
Trial Sponsors	Dana-Farber Cancer Institute
Trial Collaborators	Stand Up To Cancer
NCT Identifier	NCT03689595

Am I Eligible?

The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.

The following criteria is provided for health care professionals.